114 S2512 ES: Adding Zika Virus to the FDA Priority Review Voucher Program Act U.S. Senate text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

114th CONGRESS2d SessionS. 2512IN THE SENATE OF THE UNITED STATESAN ACTTo expand the tropical disease product priority review voucher program to encourage treatments for Zika virus.

1.

Short title

This Act may be cited as the Adding Zika Virus to the FDA Priority Review Voucher Program Act.

2.

Expanding tropical disease product priority review voucher program to encourage treatments for Zika Virus Disease

Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended— (1)by redesignating subparagraph (R) as subparagraph (S); (2)in subparagraph (Q), by striking Filoviruses and inserting Filovirus Diseases; and (3)by inserting after subparagraph (Q) the following: (R)Zika Virus Disease..

Passed the Senate March 17, 2016.Secretary